---
title: "Agenus Jumps 99% on $340M Raise for Phase 3 Colon Cancer Trial"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292518708.md"
description: "Agenus (AGEN) surged 99% to $6.665 after announcing $340M private placement to advance Phase 3 colon cancer trial."
datetime: "2026-07-13T17:51:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292518708.md)
  - [en](https://longbridge.com/en/news/292518708.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292518708.md)
generator: "portal-rs"
---

# Agenus Jumps 99% on $340M Raise for Phase 3 Colon Cancer Trial

安帝君斯 (AGEN.US) 盘中涨近**99%**，现报**6.665 美元**。

公司宣布完成**3.4 亿美元**私募融资，用于推进战略药物研发至三期临床试验，特别是即将开展的 ROBBIN 试验，针对早期结肠癌治疗。

此前公司公布了 botensilimab 联合 balstilimab 治疗难治性结直肠癌的三年一期 b 期积极数据，显示出持久的生存获益，推动股价大幅上涨。

### Related Stocks

- [AGEN.US](https://longbridge.com/en/quote/AGEN.US.md)

## Related News & Research

- [Agenus to present 3-year survival data for botensilimab-balstilimab ovarian cancer study at IGCS 2026](https://longbridge.com/en/news/298588901.md)
- [Agenus releases corporate overview presentation on botensilimab-balstilimab neoadjuvant colon cancer data](https://longbridge.com/en/news/297820304.md)
- [8 firearms that quietly doubled in value without any media attention](https://longbridge.com/en/news/298836651.md)
- [Baxter International (BAX) Could Be 17% Undervalued Following Its Hospital Recovery Narrative](https://longbridge.com/en/news/298839307.md)
- [REG - State Street Global SEGRO PLC Prologis, Inc. - Form 8.3 - Prologis, Inc.](https://longbridge.com/en/news/298924162.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**